IL183554A - Oral immediate release formulation of a poorly water-soluble active substance - Google Patents
Oral immediate release formulation of a poorly water-soluble active substanceInfo
- Publication number
- IL183554A IL183554A IL183554A IL18355407A IL183554A IL 183554 A IL183554 A IL 183554A IL 183554 A IL183554 A IL 183554A IL 18355407 A IL18355407 A IL 18355407A IL 183554 A IL183554 A IL 183554A
- Authority
- IL
- Israel
- Prior art keywords
- active substance
- immediate release
- release formulation
- poorly water
- soluble active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63811104P | 2004-12-23 | 2004-12-23 | |
EP04106933 | 2004-12-23 | ||
PCT/EP2005/056970 WO2006067150A1 (en) | 2004-12-23 | 2005-12-20 | Oral immediate release formulation of a poorly watersoluble active substance |
Publications (2)
Publication Number | Publication Date |
---|---|
IL183554A0 IL183554A0 (en) | 2007-09-20 |
IL183554A true IL183554A (en) | 2011-07-31 |
Family
ID=35890662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL183554A IL183554A (en) | 2004-12-23 | 2007-05-30 | Oral immediate release formulation of a poorly water-soluble active substance |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR20070104890A (de) |
DE (1) | DE602005019919D1 (de) |
IL (1) | IL183554A (de) |
NO (1) | NO20073728L (de) |
-
2005
- 2005-12-20 KR KR1020077016935A patent/KR20070104890A/ko not_active Application Discontinuation
- 2005-12-20 DE DE602005019919T patent/DE602005019919D1/de active Active
-
2007
- 2007-05-30 IL IL183554A patent/IL183554A/en not_active IP Right Cessation
- 2007-07-18 NO NO20073728A patent/NO20073728L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL183554A0 (en) | 2007-09-20 |
DE602005019919D1 (de) | 2010-04-22 |
NO20073728L (no) | 2007-07-18 |
KR20070104890A (ko) | 2007-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1077218A1 (en) | Oral solid solution formulation of a poorly water-soluble active substance | |
IL177120A0 (en) | Formulations for poorly soluble drugs | |
IL179992A0 (en) | Immediate release formulations of memantine oral dosage forms | |
HK1129590A1 (en) | Multiple unit type sustained release oral formulation and process for the preparation thereof | |
ZA200705530B (en) | Sustained release pharmaceutical formulations | |
IL181680A0 (en) | Tablets with site time -controlled gastrointestinal release of active ingredient | |
ZA200703571B (en) | Gabapentin prodrug sustained release oral dosage forms | |
IL180031A0 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
EP1895991A4 (de) | Formulierungen mit modifizierter freisetzung von arzneimitteln gegen erregbarkeit | |
ZA200804427B (en) | Nanoparticulate active ingredient formulations | |
TWI319317B (en) | Modified release pharmaceutical formulation | |
IL178475A0 (en) | Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof | |
FR2904219B1 (fr) | Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant | |
EP1753405A4 (de) | Pharmazeutische formulierung mit kontrollierter freisetzung | |
HK1113308A1 (en) | Pharmaceutical formulations of gallium salts | |
EP1750680A4 (de) | Druckbeschichtete formulierungen mit kontrollierter freisetzung aus wasserlöslichen wirkstoffen | |
EP1755568A4 (de) | Formulierung mit kontrollierter freisetzung zur oralen verabreichung von metformin | |
IL165069A0 (en) | Immediate release pharmaceutical formulation | |
PL1848439T3 (pl) | Doustna formulacja o natychmiastowym uwalnianiu słabo rozpuszczalnej w wodzie substancji aktywnej | |
IL183554A (en) | Oral immediate release formulation of a poorly water-soluble active substance | |
ZA200705021B (en) | Oral immediate release formulation of a poorly water-soluble active substance | |
HK1122731A1 (en) | Prolonged release formulation of active pharmaceutical ingredients | |
ZA200705080B (en) | Aminocarboxylic acid derivative and medicinal use thereof | |
ZA200810478B (en) | Oral pharmaceutical composition of a poorly water-soluble active substance | |
ZA200810240B (en) | Oral pharmaceutical composition of a poorly water-soluble active substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |